Breakthrough Cancer Drug Delivery Platform with Direct Active Entry into the Lymphatic System presented via Hidden GEMS Program from One Million Solutions in Health
Share Article
Through its Hidden GEMS Program and this science developed by the NIH, One Million Solutions in Health offers the chance to learn about licensing new science that could significantly benefit the development of both new and current cancer drugs.
Cancer Drug Delivery Platform with Direct Active Entry into the Lymphatic System
Dr. Stephan T. Stern has developed this Polylysine Succinate platform which has the ability to replace liposome and micellar systems, and become the new Gold Standard.